In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Unity Biotechnology Inc (NASDAQ: UBX) closed the day trading at $0.81 down -10.21% from the previous closing price of $0.90. In other words, the price has decreased by -$10.21 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
For a better understanding of UBX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 1.95.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On November 16, 2023, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Nguyen Alexander Hieu sold 17,852 shares for $1.03 per share. The transaction valued at 18,388 led to the insider holds 48,753 shares of the business.
Nguyen Alexander Hieu bought 17,852 shares of UBX for $18,305 on Apr 02 ’25. On Apr 02 ’25, another insider, Sullivan Lynne Marie, who serves as the CFO & Head of Corp. Dev. of the company, sold 21,867 shares for $1.03 each. As a result, the insider received 22,523 and left with 98,905 shares of the company.
Stock Price History:
Over the past 52 weeks, UBX has reached a high of $3.10, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is -33.10%, while the 200-Day Moving Average is calculated to be -43.19%.
Shares Statistics:
A total of 17.21M shares are outstanding, with a floating share count of 15.55M. Insiders hold about 9.66% of the company’s shares, while institutions hold 14.41% stake in the company.
